Email Us

Individualized Medication Guidance for Cancer (800 Genes)

This test detects 800 genes related to targeted therapy, chemotherapy and endocrine drug, hereditary tumor, immunotherapy-related information (MSI and TMB), tumor core signaling pathway and tumor prognosis. The types of variants detected include SNV, InDel, amplifications and gene fusions, helping doctors formulate professional and individualized treatment plans for patients.

individualized medication guidance for cancer 800 genes

Features of Individualized Medication Guidance for Cancer (800 Genes)

Features of Individualized Medication Guidance for Cancer (800 Genes)

Applicable Population of Individualized Medication Guidance for Cancer (800 Genes)

  • Patients with locally advanced or metastatic tumors looking for targeted drug therapy.

  • Patients with locally advanced or metastatic solid tumors and expecting immunotherapy, but no definitive driver genes been diagnosed.

  • Patients with locally advanced or metastatic solid tumors who are undergoing targeted therapy/immunotherapy, expecting dynamic monitoring of treatment through NGS.

Specification of Individualized Medication Guidance for Cancer (800 Genes)

Sample typesFresh tissue + venous blood / Paraffin specimen + venous blood / Venous blood
TAT10 working days


Products
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing